Emmanuelle di Tomaso

Person

Lexington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Dosage regimen for an alpha-isoform selective phosphatidylinositol...
- Patent number 10,434,092
- Issue date Oct 8, 2019
- Novartis AG
- Emmanuelle di Tomaso
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of a PI3 kinase inhibitor with pacitaxel for use in the...
- Patent number 9,913,846
- Issue date Mar 13, 2018
- Novartis AG
- Samit Hirawat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synergistic combinations of PI3K- and MEK-inhibitors
- Patent number 9,675,595
- Issue date Jun 13, 2017
- Novartis AG
- Christine Fritsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL...
- Publication number 20210196696
- Publication date Jul 1, 2021
- Novartis AG
- Emmanuelle di Tomaso
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH A PI3K INHIBITOR IN A PATIENT PRESELECTED...
- Publication number 20200138824
- Publication date May 7, 2020
- Novartis AG
- Emmanuelle di Tomaso
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CANCERS WITH COVALENT INHIBIT...
- Publication number 20200113902
- Publication date Apr 16, 2020
- Nisha Rajagopal
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL...
- Publication number 20200069670
- Publication date Mar 5, 2020
- Novartis AG
- Emmanuelle di Tomaso
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH A PI3K INHIBITOR IN A PATIENT PRESSELECTED...
- Publication number 20180353515
- Publication date Dec 13, 2018
- Novartis AG
- Emmanuelle di Tomaso
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DOSAGE REGIMEN FOR A PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR
- Publication number 20180280370
- Publication date Oct 4, 2018
- Novartis AG
- Christian Schnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL...
- Publication number 20180078540
- Publication date Mar 22, 2018
- Novartis AG
- Emmanuelle di Tomaso
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the...
- Publication number 20170173032
- Publication date Jun 22, 2017
- Novartis AG
- Samit Hirawat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL...
- Publication number 20170000778
- Publication date Jan 5, 2017
- Emmanuelle di Tomaso
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Combinations
- Publication number 20160129003
- Publication date May 12, 2016
- Novartis AG
- Samit Hirawat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the...
- Publication number 20160082012
- Publication date Mar 24, 2016
- Samit Hirawat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNERGISTIC COMBINATIONS OF PI3K- AND MEK-INHIBITORS
- Publication number 20140179744
- Publication date Jun 26, 2014
- Fritsch Christine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Emmanuelle di Tomaso

Person

Patents Grantslast 30 patents

Dosage regimen for an alpha-isoform selective phosphatidylinositol...

Combination of a PI3 kinase inhibitor with pacitaxel for use in the...

Synergistic combinations of PI3K- and MEK-inhibitors

Patents Applicationslast 30 patents

DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL...

TREATMENT OF CANCER WITH A PI3K INHIBITOR IN A PATIENT PRESELECTED...

COMPOSITIONS AND METHODS FOR TREATING CANCERS WITH COVALENT INHIBIT...

DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL...

TREATMENT OF CANCER WITH A PI3K INHIBITOR IN A PATIENT PRESSELECTED...

DOSAGE REGIMEN FOR A PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR

DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL...

Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the...

DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL...

Pharmaceutical Combinations

Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the...

SYNERGISTIC COMBINATIONS OF PI3K- AND MEK-INHIBITORS